Guidance
6 Related NICE guidance
6 Related NICE guidance
-
Omalizumab for severe persistent allergic asthma. NICE technology appraisal guidance 133 (2007).
-
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years. NICE technology appraisal guidance 131 (2007).
-
Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years). NICE technology appraisal guidance 38 (2002).
-
Inhaler systems (devices) in children under the age of 5 years with chronic asthma. NICE technology appraisal guidance 10 (2000).